![CONSORT diagram of the study flow. Abbreviations: FAS, Full Analysis... | Download Scientific Diagram CONSORT diagram of the study flow. Abbreviations: FAS, Full Analysis... | Download Scientific Diagram](https://www.researchgate.net/publication/346498976/figure/fig1/AS:966689936134144@1607488249351/CONSORT-diagram-of-the-study-flow-Abbreviations-FAS-Full-Analysis-Set-SAS-Safety.png)
CONSORT diagram of the study flow. Abbreviations: FAS, Full Analysis... | Download Scientific Diagram
![Patient disposition in the full analysis set (FAS) and full analysis... | Download Scientific Diagram Patient disposition in the full analysis set (FAS) and full analysis... | Download Scientific Diagram](https://www.researchgate.net/publication/317649147/figure/fig2/AS:614004867227655@1523401576104/Patient-disposition-in-the-full-analysis-set-FAS-and-full-analysis-set-preference-no.png)
Patient disposition in the full analysis set (FAS) and full analysis... | Download Scientific Diagram
![The CONSORT flow chart. FA (full analysis) set, and PP (per protocol) set. | Download Scientific Diagram The CONSORT flow chart. FA (full analysis) set, and PP (per protocol) set. | Download Scientific Diagram](https://www.researchgate.net/publication/353538872/figure/fig1/AS:1050752910905344@1627530424809/The-CONSORT-flow-chart-FA-full-analysis-set-and-PP-per-protocol-set.png)
The CONSORT flow chart. FA (full analysis) set, and PP (per protocol) set. | Download Scientific Diagram
![Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram](https://www.researchgate.net/publication/51712568/figure/fig3/AS:280374765735962@1443857961681/Patient-disposition-SAF-safety-analysis-set-FAS-full-analysis-set-PPS-per-protocol.png)
Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram
Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial | PLOS ONE
![Frontiers | Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial Frontiers | Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial](https://www.frontiersin.org/files/Articles/936925/fphar-13-936925-HTML-r1/image_m/fphar-13-936925-t004.jpg)
Frontiers | Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial
![JCM | Free Full-Text | Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia JCM | Free Full-Text | Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia](https://www.mdpi.com/jcm/jcm-11-03810/article_deploy/html/images/jcm-11-03810-g001.png)
JCM | Free Full-Text | Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia
![Randomized phase II study of nab‐paclitaxel as first‐line chemotherapy in patients with HER2‐negative metastatic breast cancer - Tamura - 2017 - Cancer Science - Wiley Online Library Randomized phase II study of nab‐paclitaxel as first‐line chemotherapy in patients with HER2‐negative metastatic breast cancer - Tamura - 2017 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b924feb9-e176-4656-86f6-570bbc62a9c4/cas13221-fig-0001-m.png)
Randomized phase II study of nab‐paclitaxel as first‐line chemotherapy in patients with HER2‐negative metastatic breast cancer - Tamura - 2017 - Cancer Science - Wiley Online Library
![The All Randomized/Full Analysis Set (ICH E9)—May Patients be Excluded from the Analysis? | Semantic Scholar The All Randomized/Full Analysis Set (ICH E9)—May Patients be Excluded from the Analysis? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a000d1a89a3db891de4b3bb3228abdc3279a2e86/2-Table1-1.png)
The All Randomized/Full Analysis Set (ICH E9)—May Patients be Excluded from the Analysis? | Semantic Scholar
![Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder - Journal of the American Academy of Child & Adolescent Psychiatry Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/asset/c538884a-a227-4325-9eaf-5125addea69b/gr1.jpg)
Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder - Journal of the American Academy of Child & Adolescent Psychiatry
![Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/c0a81b87-8ceb-4bbf-a493-55c6d4121bf6/gr1_lrg.jpg)
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity
![Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43018-022-00503-w/MediaObjects/43018_2022_503_Fig1_HTML.png)
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer
![Subject disposition. Full analysis set (FAS) = all randomised subjects... | Download Scientific Diagram Subject disposition. Full analysis set (FAS) = all randomised subjects... | Download Scientific Diagram](https://www.researchgate.net/publication/262884185/figure/fig1/AS:272046726840330@1441872402241/Subject-disposition-Full-analysis-set-FAS-all-randomised-subjects-who-received-1.png)